New COVID-19 drugs approved for fast and accurate diagnosis: China’s top epidemiologist
China’s
National Medical Product Administration has issued approvals for several types
of drugs that are effective for diagnosing novel coronavirus pneumonia or
COVID-19, the country’s top epidemiologist and leading government medical
adviser Zhong Nanshan announced on Sunday, February 23.
Zhong
shared the news on Sunday afternoon during a video conference while conducting
a special medical consultation with doctors in Jingzhou, Central China’s Hubei
Province and medics from South China’s Guangdong Province who were sent to
help.
According
to Zhong, a special drug developed by Beijing-based CapitalBio Corp was among
the drugs mentioned. It is capable of differentiating COVID-19 infection from
that of regular influenza, which is of urgent value as an influenza outbreak is
also occurring in the US as well as in China.
Also,
two examination toolkits developed by Guangzhou firm Wondfo and Tangshan’s
Innovita both focusing on observation of the patient’s immunoglobulin M (IgM)
inside his or her body, as the IgM would emerge as a special response body to
the virus after seven days of infection or three days into the onset of
symptoms, were also approved by the regulator.
They
would be especially useful in Hubei, Zhong noted.
Source:Global Times
On February 21, 2020, another
batch of cured patients were discharged from the Central Theater General
Hospital, and the attending doctor presented flowers to the elderly. (Photo by
Wang Haoyu, People’s Daily Online)
New COVID-19 drugs approved for fast and accurate diagnosis: China’s top epidemiologist
Reviewed by PEOPLES MAIL
on
07:35
Rating:
No comments: